About
Pulsenmore has developed a reliable, universally accessible home ultrasound device for remote care. Its technology enables patients to self-scan by connecting their own smartphone to a novel handheld ultrasound cradle. Scans are automatically sent for remote clinical assessment by healthcare providers. Pulsenmores at-home prenatal ultrasound for remote assessment of fetal well-being empowers women to proactively manage their pregnancies in collaboration with their healthcare providers. The technology aims to enhance the availability of care, improve resource management, and increase patient satisfaction. The Pulsenmore home ultrasound system for fetal monitoring has CE and AMAR certification and is commercially available across Europe and Israel; in the U.S. the system is limited under federal law to investigational use only.
Funding history · 4 rounds · $110.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When did Pulsenmore become a publicly traded company and on which exchange?
- Pulsenmore became public on the TASE (Tel Aviv Stock Exchange) in June 2021, with an IPO valuation of $190M.
- What significant funding did Pulsenmore receive in May 2022 and from whom?
- In May 2022, Pulsenmore received a $50,000,000 PIPE investment, with General Electric as the lead investor.
- What regulatory milestone did Pulsenmore achieve in the U.S. in November 2025?
- In November 2025, Pulsenmore received FDA De Novo Marketing Authorization for its home-use prenatal ultrasound device, enabling its commercial expansion in the U.S.
- What new commercial engagement did Pulsenmore announce in February 2026?
- In February 2026, Pulsenmore announced a new commercial engagement with TLC, following its FDA clearance.
- What new service did Pulsenmore launch with Clalit Health Services in January 2026?
- In January 2026, Pulsenmore and Clalit Health Services launched the first at-home follicular monitoring service for IVF and fertility preservation.
- When did Pulsenmore expand its partnership with Clalit Health Services for home ultrasound devices?
- In October 2024, Pulsenmore expanded its partnership with Clalit Health Services to deliver 25,000 home ultrasound devices for remote prenatal care.
- What was a key operational development for Pulsenmore in April 2022?
- In April 2022, Pulsenmore established its U.S. operations and appointed a General Manager for North America.
- What was the purpose of the clinical trial Pulsenmore initiated with Michigan Medicine in March 2024?
- In March 2024, Pulsenmore initiated a clinical trial with Michigan Medicine to expand the application of its home ultrasound solution for pregnant women, focusing on the remote assessment of the fetal biophysical profile.
- What regulatory approval did Pulsenmore receive in Brazil in January 2024?
- In January 2024, Pulsenmore received Brazilian ANVISA approval for its prenatal home ultrasound solution.